Literature DB >> 33607970

Time series analysis of the relationship between diarrhea in children and Rota 2 vaccine in the Fanteakwa District of the eastern region of Ghana.

James Atampiiga Avoka1, Elvis J Dun-Dery2, Issah Seidu3,4,5,6, Armel N E Abou3,4,5,6, Paul Twene3,4,5,6, Isaac Obeng Tandoh3,4,5,6, Frederick Dun-Dery7.   

Abstract

BACKGROUND: Rotavirus is considered the main causal factor of severe gastroenteritis among infants and children globally. The association with severe rotavirus infection is mostly worse among the least developed countries, mainly due to inadequate access to medical care and poverty. This study was conducted to determine the seasonal effects in respect of diarrhea cases in children, the association between diarrhea cases and Rota2 vaccine in the Fanteakwa District of the Eastern Region of Ghana.
METHODS: The study compares monthly diarrhea cases against children vaccinated with Rota2 extracted from DHIMS2 spanning May 2012 to December 2017 in Fanteakwa District. A univariate association between diarrhea cases and children vaccinated with Rota 2 was conducted using the R-software version 3.4.4 with the use of forecast, tseries and TSAPred. Pearson Correlation coefficient was also computed between monthly diarrhea cases and Rota 2 as well as lagged values of Rota 2 and Diarrhea cases.
RESULTS: The study shows that February recorded the highest average number of diarrhea cases (172) over the period 2012 to 2017 with a standard deviation of 59. However, a one-way analysis of variance shows a significant difference amongst the monthly averages with an F-statistic of 0.042 and P-value of 0.064. It is observed that the correlations between each of the Rota2 doses and the lagged cases are positive, showing higher Rota2 doses a month ago ((Xt - 1),0.346 to 0.735), two months ago ((Xt - 2),0.383 to 0.746), three months ago ((Xt - 3), 0.330 to 0.737) and four months ago ((Xt - 4), 0.236 to 0.723) are associated with lower diarrhea cases. The results also show that an increase in the previous two month's Rota2 figures by 100 is associated with a significant decrease in the currently expected diarrhea cases by approximately 36.
CONCLUSION: Seasonal variations exist in the occurrence of diarrhea in children, with January recording the highest number of diarrhea cases (172). There is a relationship between episodes of diarrhea in children and Rota2 (p-value = 0.064); thus, the more children are vaccinated with Rota2, the less diarrhea cases are recorded. Diarrhea cases in Fanteakwa district are generally low, except 2013 and 2016 where the cases are higher than the rest of the other years.

Entities:  

Keywords:  Children; Diarrhea; Ghana; Rotavirus

Year:  2021        PMID: 33607970      PMCID: PMC7893935          DOI: 10.1186/s12887-021-02540-3

Source DB:  PubMed          Journal:  BMC Pediatr        ISSN: 1471-2431            Impact factor:   2.125


  34 in total

1.  Rotavirus vaccine and health care utilization for diarrhea in U.S. children.

Authors:  Jennifer E Cortes; Aaron T Curns; Jacqueline E Tate; Margaret M Cortese; Manish M Patel; Fangjun Zhou; Umesh D Parashar
Journal:  N Engl J Med       Date:  2011-09-22       Impact factor: 91.245

Review 2.  Rotavirus vaccines: current prospects and future challenges.

Authors:  Roger I Glass; Umesh D Parashar; Joseph S Bresee; Reina Turcios; Thea K Fischer; Marc-Alain Widdowson; Baoming Jiang; Jon R Gentsch
Journal:  Lancet       Date:  2006-07-22       Impact factor: 79.321

3.  Large increase of rotavirus diarrhoea in the hospital setting associated with emergence of G12 genotype in a highly vaccinated population in Nicaragua.

Authors:  F Bucardo; J Mercado; Y Reyes; F González; A Balmaseda; J Nordgren
Journal:  Clin Microbiol Infect       Date:  2015-02-09       Impact factor: 8.067

Review 4.  Rotarix: a rotavirus vaccine for the world.

Authors:  Richard L Ward; David I Bernstein
Journal:  Clin Infect Dis       Date:  2009-01-15       Impact factor: 9.079

5.  Nitazoxanide vs. probiotics for the treatment of acute rotavirus diarrhea in children: a randomized, single-blind, controlled trial in Bolivian children.

Authors:  Carlos G Teran; Carlos N Teran-Escalera; Patricia Villarroel
Journal:  Int J Infect Dis       Date:  2008-12-12       Impact factor: 3.623

6.  Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants.

Authors:  P Hanlon; L Hanlon; V Marsh; P Byass; F Shenton; M Hassan-King; O Jobe; H Sillah; R Hayes; B H M'Boge
Journal:  Lancet       Date:  1987-06-13       Impact factor: 79.321

7.  Diarrhea incidence and intestinal infections among rotavirus vaccinated infants from a poor area in Brazil: a spatial analysis.

Authors:  Claudimary Bispo Santos; Karina Conceição G M Araújo; Anne Jardim-Botelho; Márcio Bezerra Santos; Alda Rodrigues; Silvio Santana Dolabella; Ricardo Queiroz Gurgel
Journal:  BMC Public Health       Date:  2014-04-24       Impact factor: 3.295

8.  Household wealth, residential status and the incidence of diarrhoea among children under-five years in Ghana.

Authors:  Akwasi Kumi-Kyereme; Joshua Amo-Adjei
Journal:  J Epidemiol Glob Health       Date:  2015-06-10

9.  Cost-effectiveness of rotavirus vaccination in Ghana: Examining impacts from 2012 to 2031.

Authors:  Justice Nonvignon; Deborah Atherly; Clint Pecenka; Moses Aikins; Lauren Gazley; Devin Groman; Clement T Narh; George Armah
Journal:  Vaccine       Date:  2017-12-06       Impact factor: 3.641

10.  Rotavirus genotypes associated with childhood severe acute diarrhoea in southern Ghana: a cross-sectional study.

Authors:  Christabel C Enweronu-Laryea; Kwamena W Sagoe; Susan Damanka; Belinda Lartey; George E Armah
Journal:  Virol J       Date:  2013-09-14       Impact factor: 4.099

View more
  1 in total

1.  Factors associated with dehydrating rotavirus diarrhea in children under five in Bangladesh: An urban-rural comparison.

Authors:  Sultana Yeasmin; S M Tafsir Hasan; Mohammod Jobayer Chisti; Md Alfazal Khan; A S G Faruque; Tahmeed Ahmed
Journal:  PLoS One       Date:  2022-08-26       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.